Related Experiment Video
Updated: Sep 14, 2025

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
Algerian Tuberculosis Control Program: 60 Years of Successful Experience
Kada Bentata1, Sofiane Alihalassa2, Merzak Gharnaout3
1Pulmonology Department, Mostaganem University Hospital, Faculty of Medicine, Abdelhamid Ibn Badis University, Mostaganem, DZA.
Algeria has significantly reduced tuberculosis rates through dedicated public health strategies and WHO collaboration. These efforts have maintained lower prevalence and incidence of this infectious disease for years.
Area of Science:
- Public Health
- Epidemiology
- Infectious Disease Control
Background:
- Tuberculosis (TB) remains a significant global health challenge, particularly in low-to-moderate income nations.
- Algeria has prioritized TB control within its national public health strategy since its independence in 1962.
- The country has focused on economic and healthcare development to support disease control initiatives.
Discussion:
- Algeria's commitment to TB control has led to a substantial decrease in disease prevalence and incidence.
- Collaboration with World Health Organization (WHO) programs has been instrumental in advancing TB control efforts.
- Sustained efforts have maintained reduced TB rates over several years, indicating program effectiveness.
Key Insights:
- The successful reduction of tuberculosis, especially the pulmonary form, highlights the efficacy of targeted public health interventions.
- Algeria's progress demonstrates a model for other nations facing similar infectious disease burdens.
- Long-term maintenance of decreased TB rates signifies the sustainability of the implemented control programs.
Outlook:
- Continued vigilance and adaptation of control strategies are essential to maintain the achieved progress.
- Further research into Algeria's specific TB control program components could offer valuable insights for global strategies.
- Sustaining economic and healthcare development will be crucial for the long-term success of infectious disease management in Algeria.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

